As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.

Translate

French German Italian Portuguese Russian

Clinical Trials

Chronic Lymphocytic Leukemia in Patients 70 Years of Age and Older Treatment Study

Ibrutinib and obinutuzumab with or without venetoclax in treating older patients with untreated chronic lymphocytic leukemia.

Chronic Lymphocytic Leukemia in Younger Patients Treatment Study

Ibrutinib and obinutuzumab with or without venetoclax in treating patients with chronic lymphocytic leukemia.